Adamis Pharmaceuticals reported 30.55M in Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Adamis Pharmaceuticals ADMP:US 30.55M 7.75M
Adma Biologics ADMA:US $ 308.03M 31.78M
Brainstorm Cell Therapeutics BCLI:US $ 25.79M 3.49M
Cara Therapeutics CARA:US $ 223.87M 23.19M
Cerulean Pharma CERU:US $ 49.19M 6.62M
GlaxoSmithKline GSK:LN 89689M 10586M
Glaxosmithkline GSK:US $ 89689M 10586M
Merk MRK:US $ 106668M 974M
Redhill Biopharma RDHL:US $ 167.05M 14.14M